Product Information
ZOLPIDEM TART ER 12.5 MG TAB is a generic product labeled by Sanofi-Aventis U.S. LLC, priced at $0.1130 per EA under NDC 00955170310. Its NADAC has been published 653 times since Nov 28, 2013.
FDA first approved this application on Sep 2, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the zolpidem tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00955170310
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
ZOLPIDEM TARTRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021774FDA Approved
9/2/2005
TE Code
AB
On Market Since
12/6/2010
Pharmacological Classes
Price Statistics
The NADAC for ZOLPIDEM TART ER 12.5 MG TAB has been published 653 times since Nov 28, 2013, and over the history we have for it it has declined 95.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1130 per EA |
|---|---|
| All-time high | $2.5169 (Apr 16, 2014) |
| All-time low | $0.0893 (Nov 20, 2024) |
| 52-week high | $0.1225 |
| 52-week low | $0.1108 |
| Median price | $0.3780 |
| Average price | $0.7354 |
| Largest weekly change | +69.7% (Sep 23, 2020) |
| Weeks tracked | 653 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
0.0%
6M
+1.8%
1Y
-7.7%
3Y
-32.1%
5Y
-66.5%
All
-95.2%
Last surveyed May 27, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZOLPIDEM TART ER 12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for ZOLPIDEM TART ER 12.5 MG TAB, manufactured by Sanofi-Aventis U.S. LLC, is $0.1130 per EA (NDC 00955170310), effective May 27, 2026.
How has the price of ZOLPIDEM TART ER 12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for ZOLPIDEM TART ER 12.5 MG TAB has declined 95.2%. It has been tracked across 653 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZOLPIDEM TART ER 12.5 MG TAB?
Since Nov 28, 2013, the NADAC for ZOLPIDEM TART ER 12.5 MG TAB has ranged from a low of $0.0893 (Nov 20, 2024) to a high of $2.5169 (Apr 16, 2014), with a median of $0.3780 per EA.
Are there cheaper alternatives to ZOLPIDEM TART ER 12.5 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZOLPIDEM TART ER 12.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures ZOLPIDEM TART ER 12.5 MG TAB?
ZOLPIDEM TART ER 12.5 MG TAB (NDC 00955170310) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a generic product.